Knight Therapeutics Inc. places No. 384 on The Globe and Mail's seventh annual ranking of Canada's Top Growing Companies

Core Insights - Knight Therapeutics Inc. has been ranked No. 384 on the 2025 Report on Business magazine's list of Canada's Top Growing Companies, achieving a three-year revenue growth of 53% [1][2] Company Performance - The recognition marks the fifth consecutive year that Knight has been named one of Canada's Top Growing Companies, reflecting the company's commitment to innovation and strategic vision [2] - Knight has expanded its product pipeline and existing sales through acquisitions from Paladin Pharma and Sumitomo Canada, as well as strengthened partnerships with Helsinn and Incyte [2] Industry Recognition - The ranking is part of an editorial initiative launched in 2019 to celebrate innovative businesses in Canada, with 400 companies making the list this year [2][3] - The annual ranking aims to highlight the ingenuity of Canadian entrepreneurs and corporate leaders, inspiring future generations [3] Company Overview - Knight Therapeutics Inc. is a specialty pharmaceutical company based in Montreal, focused on acquiring and commercializing pharmaceutical products for Canada and Latin America [5] - The company's shares are traded on the TSX under the symbol GUD [5]